Production (Stage)
Allarity Therapeutics, Inc.
ALLR
$1.03
-$0.035-3.29%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.20M | 19.61M | 18.46M | 19.23M | 312.00K |
| Total Receivables | 1.12M | 2.23M | 1.65M | 1.58M | 1.33M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 493.00K | 507.00K | 151.00K | 366.00K | 542.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.61M | -- | 100.00K | 131.00K | 110.00K |
| Total Current Assets | 29.42M | 22.34M | 20.37M | 21.31M | 2.30M |
|
|
|||||
| Total Current Assets | 29.42M | 22.34M | 20.37M | 21.31M | 2.30M |
| Net Property, Plant & Equipment | 308.00K | 309.00K | 12.00K | 17.00K | 18.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 9.56M | 9.66M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 29.73M | 22.65M | 20.38M | 30.88M | 11.97M |
|
|
|||||
| Total Accounts Payable | 4.35M | 4.18M | 4.69M | 7.75M | 11.06M |
| Total Accrued Expenses | 2.78M | 2.73M | 1.32M | 1.47M | 1.55M |
| Short-term Debt | -- | -- | -- | -- | 2.69M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.36M | 1.35M | 1.34M | 1.33M | -- |
| Total Finance Division Other Current Liabilities | 2.58M | 2.58M | 62.00K | 73.00K | 2.71M |
| Total Other Current Liabilities | 2.58M | 2.58M | 62.00K | 73.00K | 2.71M |
| Total Current Liabilities | 11.06M | 10.84M | 7.41M | 10.62M | 18.01M |
|
|
|||||
| Total Current Liabilities | 11.06M | 10.84M | 7.41M | 10.62M | 18.01M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 2.69M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 432.00K | 432.00K |
| Total Liabilities | 11.06M | 10.84M | 7.41M | 11.05M | 18.44M |
|
|
|||||
| Common Stock & APIC | 141.00M | 131.13M | 125.17M | 120.29M | 90.70M |
| Retained Earnings | -121.70M | -118.97M | -111.51M | -99.92M | -98.29M |
| Treasury Stock & Other | -630.00K | -354.00K | -693.00K | -530.00K | -386.00K |
| Total Common Equity | 18.67M | 11.81M | 12.96M | 19.84M | -7.98M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 1.51M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 1.51M |
|
|
|||||
| Total Common Equity | 18.67M | 11.81M | 12.96M | 19.84M | -7.98M |
| Total Preferred Equity | -- | -- | -- | -- | 1.51M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.67M | 11.81M | 12.96M | 19.84M | -6.47M |
|
|
|||||